Loading…

A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes

•TX527, a 1α,25(OH)2D3 analog, alters the global protein profile of human T cells.•TX527 affects proteins involved in energy/protein metabolism and cytoskeleton.•TX527 induces PTMs of several proteins found in multiple isoforms.•Transcription and translation of a few genes is differently affected by...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of steroid biochemistry and molecular biology 2014-10, Vol.144, p.96-101
Main Authors: Ferreira, G.B., Baeke, F., Verstuyf, A., De Clercq, P., Waelkens, E., Mathieu, C., Overbergh, L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c294t-292858b6514cc0d4cd166dba2882f8e3ee10f6a5e12204c1b47749eedcc04d943
container_end_page 101
container_issue
container_start_page 96
container_title The Journal of steroid biochemistry and molecular biology
container_volume 144
creator Ferreira, G.B.
Baeke, F.
Verstuyf, A.
De Clercq, P.
Waelkens, E.
Mathieu, C.
Overbergh, L.
description •TX527, a 1α,25(OH)2D3 analog, alters the global protein profile of human T cells.•TX527 affects proteins involved in energy/protein metabolism and cytoskeleton.•TX527 induces PTMs of several proteins found in multiple isoforms.•Transcription and translation of a few genes is differently affected by TX527. 1α,25-Dihydroxyvitamin D3 (1α,25(OH)2D3), and its analogs (i.e. 14,20-bis-epi-19-nor-23-yne-1α,25(OH)2D3 – TX527) have been shown to prevent autoimmunity and prolong islet graft survival in the non-obese diabetic (NOD) mouse. Their effects are mediated by their action on various immune cell types, such as dendritic cells (DC) and T cells. We have previously reported important direct effects of TX527 on human T cells, on their cytokine/chemokine profiles, T regulatory cell markers, homing characteristics and chemotaxis. In order to fully understand the molecular mechanisms underlying the beneficial properties of TX527 on human T cells, we applied here 2-dimensional difference gel electrophoresis (2-D DIGE) to analyze the global protein alterations induced by TX527 on human synchronized T cells. We detected differential expression of 64 protein spots upon TX527 treatment, of which 65.6% could be successfully identified using tandem mass spectrometry (MALDI-TOF/TOF). The identified proteins function in various processes, such as metabolism and energy pathways, cytoskeleton and protein metabolism. When comparing the proteomics data to our previously performed microarray data on the same set of cells, we found an overlap of 17 different mRNAs/proteins. For some of these (e.g. PSME2, HSPA8), the direction of regulation was not similar, hereby reinforcing the important role of post-transcriptional/translational processes in the functionality of proteins. In addition, although 2-D DIGE offers the possibility of picking up post-translational processes, it lacks the ability to detect molecules with extreme molecular weight (MW) and isoelectrical point (pI) values, or very low abundant/hydrophobic proteins. This study highlights therefore the importance of combining different experimental approaches to obtain a complete picture of the underlying mechanisms and general processes being affected in T cells upon TX527 treatment. These processes lead altogether to the generation of T cells with interesting immunomodulatory features for clinical applications in the treatment of autoimmune diseases or in the prevention of graft rejection. This article is part of a Special
doi_str_mv 10.1016/j.jsbmb.2013.10.013
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1609307151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960076013002069</els_id><sourcerecordid>1609307151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c294t-292858b6514cc0d4cd166dba2882f8e3ee10f6a5e12204c1b47749eedcc04d943</originalsourceid><addsrcrecordid>eNp9kM9O3DAQxi1UVLa0T1Cp8rGHzeJxHDs59ID401ZC4rJI3CzHnhCvkngbZxF5LF6EZ8LbpT1y-mZGv5nR9xHyFdgKGMizzWoT675ecQZ5mqySHJEFlKrKgHP2gSxYJVnGlGQn5FOMG8ZYnoP6SE64ACVVUS2IP6fbMUwYem-p2aba2JaGgU4tUmwatFOkoaHr-4KrJTUUXp6XvMicb2c3hqf50U-m9wO9zKkZTBceljR17a43A13Tbu63bbDzhPEzOW5MF_HLm56Su-ur9cWv7Ob25--L85vM8kpMGa94WZS1LEBYy5ywDqR0teFlyZsSc0RgjTQF7j0KC7VQSlSILtHCVSI_Jd8Pd5OXPzuMk-59tNh1ZsCwixokq3KmoICE5gfUjiHGERu9HX1vxlkD0_uM9Ub_zVjvM94Pk6Stb28PdnWP7v_Ov1AT8OMAYLL56HHU0XocLDo_pjy1C_7dB69As40s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1609307151</pqid></control><display><type>article</type><title>A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes</title><source>ScienceDirect Freedom Collection</source><creator>Ferreira, G.B. ; Baeke, F. ; Verstuyf, A. ; De Clercq, P. ; Waelkens, E. ; Mathieu, C. ; Overbergh, L.</creator><creatorcontrib>Ferreira, G.B. ; Baeke, F. ; Verstuyf, A. ; De Clercq, P. ; Waelkens, E. ; Mathieu, C. ; Overbergh, L.</creatorcontrib><description>•TX527, a 1α,25(OH)2D3 analog, alters the global protein profile of human T cells.•TX527 affects proteins involved in energy/protein metabolism and cytoskeleton.•TX527 induces PTMs of several proteins found in multiple isoforms.•Transcription and translation of a few genes is differently affected by TX527. 1α,25-Dihydroxyvitamin D3 (1α,25(OH)2D3), and its analogs (i.e. 14,20-bis-epi-19-nor-23-yne-1α,25(OH)2D3 – TX527) have been shown to prevent autoimmunity and prolong islet graft survival in the non-obese diabetic (NOD) mouse. Their effects are mediated by their action on various immune cell types, such as dendritic cells (DC) and T cells. We have previously reported important direct effects of TX527 on human T cells, on their cytokine/chemokine profiles, T regulatory cell markers, homing characteristics and chemotaxis. In order to fully understand the molecular mechanisms underlying the beneficial properties of TX527 on human T cells, we applied here 2-dimensional difference gel electrophoresis (2-D DIGE) to analyze the global protein alterations induced by TX527 on human synchronized T cells. We detected differential expression of 64 protein spots upon TX527 treatment, of which 65.6% could be successfully identified using tandem mass spectrometry (MALDI-TOF/TOF). The identified proteins function in various processes, such as metabolism and energy pathways, cytoskeleton and protein metabolism. When comparing the proteomics data to our previously performed microarray data on the same set of cells, we found an overlap of 17 different mRNAs/proteins. For some of these (e.g. PSME2, HSPA8), the direction of regulation was not similar, hereby reinforcing the important role of post-transcriptional/translational processes in the functionality of proteins. In addition, although 2-D DIGE offers the possibility of picking up post-translational processes, it lacks the ability to detect molecules with extreme molecular weight (MW) and isoelectrical point (pI) values, or very low abundant/hydrophobic proteins. This study highlights therefore the importance of combining different experimental approaches to obtain a complete picture of the underlying mechanisms and general processes being affected in T cells upon TX527 treatment. These processes lead altogether to the generation of T cells with interesting immunomodulatory features for clinical applications in the treatment of autoimmune diseases or in the prevention of graft rejection. This article is part of a Special Issue entitled ‘16th Vitamin D Workshop’.</description><identifier>ISSN: 0960-0760</identifier><identifier>EISSN: 1879-1220</identifier><identifier>DOI: 10.1016/j.jsbmb.2013.10.013</identifier><identifier>PMID: 24176759</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>2-D DIGE ; Alkynes - pharmacology ; Animals ; Biomarkers - metabolism ; Cholecalciferol - pharmacology ; Humans ; Immunomodulation ; Mice ; Proteomics ; Proteomics - methods ; T cells ; T-Lymphocytes - drug effects ; T-Lymphocytes - metabolism ; Vitamin D analog</subject><ispartof>The Journal of steroid biochemistry and molecular biology, 2014-10, Vol.144, p.96-101</ispartof><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c294t-292858b6514cc0d4cd166dba2882f8e3ee10f6a5e12204c1b47749eedcc04d943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24176759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferreira, G.B.</creatorcontrib><creatorcontrib>Baeke, F.</creatorcontrib><creatorcontrib>Verstuyf, A.</creatorcontrib><creatorcontrib>De Clercq, P.</creatorcontrib><creatorcontrib>Waelkens, E.</creatorcontrib><creatorcontrib>Mathieu, C.</creatorcontrib><creatorcontrib>Overbergh, L.</creatorcontrib><title>A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes</title><title>The Journal of steroid biochemistry and molecular biology</title><addtitle>J Steroid Biochem Mol Biol</addtitle><description>•TX527, a 1α,25(OH)2D3 analog, alters the global protein profile of human T cells.•TX527 affects proteins involved in energy/protein metabolism and cytoskeleton.•TX527 induces PTMs of several proteins found in multiple isoforms.•Transcription and translation of a few genes is differently affected by TX527. 1α,25-Dihydroxyvitamin D3 (1α,25(OH)2D3), and its analogs (i.e. 14,20-bis-epi-19-nor-23-yne-1α,25(OH)2D3 – TX527) have been shown to prevent autoimmunity and prolong islet graft survival in the non-obese diabetic (NOD) mouse. Their effects are mediated by their action on various immune cell types, such as dendritic cells (DC) and T cells. We have previously reported important direct effects of TX527 on human T cells, on their cytokine/chemokine profiles, T regulatory cell markers, homing characteristics and chemotaxis. In order to fully understand the molecular mechanisms underlying the beneficial properties of TX527 on human T cells, we applied here 2-dimensional difference gel electrophoresis (2-D DIGE) to analyze the global protein alterations induced by TX527 on human synchronized T cells. We detected differential expression of 64 protein spots upon TX527 treatment, of which 65.6% could be successfully identified using tandem mass spectrometry (MALDI-TOF/TOF). The identified proteins function in various processes, such as metabolism and energy pathways, cytoskeleton and protein metabolism. When comparing the proteomics data to our previously performed microarray data on the same set of cells, we found an overlap of 17 different mRNAs/proteins. For some of these (e.g. PSME2, HSPA8), the direction of regulation was not similar, hereby reinforcing the important role of post-transcriptional/translational processes in the functionality of proteins. In addition, although 2-D DIGE offers the possibility of picking up post-translational processes, it lacks the ability to detect molecules with extreme molecular weight (MW) and isoelectrical point (pI) values, or very low abundant/hydrophobic proteins. This study highlights therefore the importance of combining different experimental approaches to obtain a complete picture of the underlying mechanisms and general processes being affected in T cells upon TX527 treatment. These processes lead altogether to the generation of T cells with interesting immunomodulatory features for clinical applications in the treatment of autoimmune diseases or in the prevention of graft rejection. This article is part of a Special Issue entitled ‘16th Vitamin D Workshop’.</description><subject>2-D DIGE</subject><subject>Alkynes - pharmacology</subject><subject>Animals</subject><subject>Biomarkers - metabolism</subject><subject>Cholecalciferol - pharmacology</subject><subject>Humans</subject><subject>Immunomodulation</subject><subject>Mice</subject><subject>Proteomics</subject><subject>Proteomics - methods</subject><subject>T cells</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - metabolism</subject><subject>Vitamin D analog</subject><issn>0960-0760</issn><issn>1879-1220</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kM9O3DAQxi1UVLa0T1Cp8rGHzeJxHDs59ID401ZC4rJI3CzHnhCvkngbZxF5LF6EZ8LbpT1y-mZGv5nR9xHyFdgKGMizzWoT675ecQZ5mqySHJEFlKrKgHP2gSxYJVnGlGQn5FOMG8ZYnoP6SE64ACVVUS2IP6fbMUwYem-p2aba2JaGgU4tUmwatFOkoaHr-4KrJTUUXp6XvMicb2c3hqf50U-m9wO9zKkZTBceljR17a43A13Tbu63bbDzhPEzOW5MF_HLm56Su-ur9cWv7Ob25--L85vM8kpMGa94WZS1LEBYy5ywDqR0teFlyZsSc0RgjTQF7j0KC7VQSlSILtHCVSI_Jd8Pd5OXPzuMk-59tNh1ZsCwixokq3KmoICE5gfUjiHGERu9HX1vxlkD0_uM9Ub_zVjvM94Pk6Stb28PdnWP7v_Ov1AT8OMAYLL56HHU0XocLDo_pjy1C_7dB69As40s</recordid><startdate>201410</startdate><enddate>201410</enddate><creator>Ferreira, G.B.</creator><creator>Baeke, F.</creator><creator>Verstuyf, A.</creator><creator>De Clercq, P.</creator><creator>Waelkens, E.</creator><creator>Mathieu, C.</creator><creator>Overbergh, L.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201410</creationdate><title>A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes</title><author>Ferreira, G.B. ; Baeke, F. ; Verstuyf, A. ; De Clercq, P. ; Waelkens, E. ; Mathieu, C. ; Overbergh, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c294t-292858b6514cc0d4cd166dba2882f8e3ee10f6a5e12204c1b47749eedcc04d943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>2-D DIGE</topic><topic>Alkynes - pharmacology</topic><topic>Animals</topic><topic>Biomarkers - metabolism</topic><topic>Cholecalciferol - pharmacology</topic><topic>Humans</topic><topic>Immunomodulation</topic><topic>Mice</topic><topic>Proteomics</topic><topic>Proteomics - methods</topic><topic>T cells</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - metabolism</topic><topic>Vitamin D analog</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferreira, G.B.</creatorcontrib><creatorcontrib>Baeke, F.</creatorcontrib><creatorcontrib>Verstuyf, A.</creatorcontrib><creatorcontrib>De Clercq, P.</creatorcontrib><creatorcontrib>Waelkens, E.</creatorcontrib><creatorcontrib>Mathieu, C.</creatorcontrib><creatorcontrib>Overbergh, L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferreira, G.B.</au><au>Baeke, F.</au><au>Verstuyf, A.</au><au>De Clercq, P.</au><au>Waelkens, E.</au><au>Mathieu, C.</au><au>Overbergh, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes</atitle><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle><addtitle>J Steroid Biochem Mol Biol</addtitle><date>2014-10</date><risdate>2014</risdate><volume>144</volume><spage>96</spage><epage>101</epage><pages>96-101</pages><issn>0960-0760</issn><eissn>1879-1220</eissn><abstract>•TX527, a 1α,25(OH)2D3 analog, alters the global protein profile of human T cells.•TX527 affects proteins involved in energy/protein metabolism and cytoskeleton.•TX527 induces PTMs of several proteins found in multiple isoforms.•Transcription and translation of a few genes is differently affected by TX527. 1α,25-Dihydroxyvitamin D3 (1α,25(OH)2D3), and its analogs (i.e. 14,20-bis-epi-19-nor-23-yne-1α,25(OH)2D3 – TX527) have been shown to prevent autoimmunity and prolong islet graft survival in the non-obese diabetic (NOD) mouse. Their effects are mediated by their action on various immune cell types, such as dendritic cells (DC) and T cells. We have previously reported important direct effects of TX527 on human T cells, on their cytokine/chemokine profiles, T regulatory cell markers, homing characteristics and chemotaxis. In order to fully understand the molecular mechanisms underlying the beneficial properties of TX527 on human T cells, we applied here 2-dimensional difference gel electrophoresis (2-D DIGE) to analyze the global protein alterations induced by TX527 on human synchronized T cells. We detected differential expression of 64 protein spots upon TX527 treatment, of which 65.6% could be successfully identified using tandem mass spectrometry (MALDI-TOF/TOF). The identified proteins function in various processes, such as metabolism and energy pathways, cytoskeleton and protein metabolism. When comparing the proteomics data to our previously performed microarray data on the same set of cells, we found an overlap of 17 different mRNAs/proteins. For some of these (e.g. PSME2, HSPA8), the direction of regulation was not similar, hereby reinforcing the important role of post-transcriptional/translational processes in the functionality of proteins. In addition, although 2-D DIGE offers the possibility of picking up post-translational processes, it lacks the ability to detect molecules with extreme molecular weight (MW) and isoelectrical point (pI) values, or very low abundant/hydrophobic proteins. This study highlights therefore the importance of combining different experimental approaches to obtain a complete picture of the underlying mechanisms and general processes being affected in T cells upon TX527 treatment. These processes lead altogether to the generation of T cells with interesting immunomodulatory features for clinical applications in the treatment of autoimmune diseases or in the prevention of graft rejection. This article is part of a Special Issue entitled ‘16th Vitamin D Workshop’.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24176759</pmid><doi>10.1016/j.jsbmb.2013.10.013</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-0760
ispartof The Journal of steroid biochemistry and molecular biology, 2014-10, Vol.144, p.96-101
issn 0960-0760
1879-1220
language eng
recordid cdi_proquest_miscellaneous_1609307151
source ScienceDirect Freedom Collection
subjects 2-D DIGE
Alkynes - pharmacology
Animals
Biomarkers - metabolism
Cholecalciferol - pharmacology
Humans
Immunomodulation
Mice
Proteomics
Proteomics - methods
T cells
T-Lymphocytes - drug effects
T-Lymphocytes - metabolism
Vitamin D analog
title A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20proteomic%20approach%20on%20the%20effects%20of%20TX527,%20a%201%CE%B1,25-dihydroxyvitamin%20D3%20analog,%20in%20human%20T%20lymphocytes&rft.jtitle=The%20Journal%20of%20steroid%20biochemistry%20and%20molecular%20biology&rft.au=Ferreira,%20G.B.&rft.date=2014-10&rft.volume=144&rft.spage=96&rft.epage=101&rft.pages=96-101&rft.issn=0960-0760&rft.eissn=1879-1220&rft_id=info:doi/10.1016/j.jsbmb.2013.10.013&rft_dat=%3Cproquest_cross%3E1609307151%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c294t-292858b6514cc0d4cd166dba2882f8e3ee10f6a5e12204c1b47749eedcc04d943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1609307151&rft_id=info:pmid/24176759&rfr_iscdi=true